SLIGHT IMPROVEMENT FOR ALCHEMIA

SLIGHT IMPROVEMENT FOR ALCHEMIA

 ALCHEMIA Limited (ASX:ACL) has recorded a $5.5 million loss for the half year to December 2013, despite positive clinical trials in oncology overseas.

The drug development company’s loss is an improvement from $5.9 million at this time last year.

Total income dropped to $5 million, down from $9.4 million in the previous period, which included a $4.5 million research and development tax incentive income.

Over the six month period, ACL reduced operating expenses and administrative costs and significantly increased net cash balances from $6.1 million to $16.4 million.

As part of the company’s commercial agreement with Dr Reddy’s Laboratories, there was a $4.7 million profit share in fondaparinux medication in the US.

ACL will continue to treat metatastic colorectal cancer patients in its Phase III HA-Irinotecan clinical study.

Transpacific boosts profit. Read here.

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How communications technology can raise the bar on customer service, employee experience
Partner Content
From capturing feedback early to providing messages with a higher rate of cut-through, ...
Advertisement

Related Stories

Australian motoring clubs acquire largest public EV charger network Chargefox

Australian motoring clubs acquire largest public EV charger network Chargefox

Australia’s largest EV charging network Chargefox, which has ...

Apollo to divest large share of motorhome fleet to get Tourism Holdings merger over the line

Apollo to divest large share of motorhome fleet to get Tourism Holdings merger over the line

In an effort to appease Australian and New Zealand regulator concer...

Dexus awards John Holland building contract in $2.1b Waterfront Brisbane project

Dexus awards John Holland building contract in $2.1b Waterfront Brisbane project

After securing an $830 million contract from Dexus (ASX: DXS), Melb...

QLD to launch Star Entertainment review in July as former judge appointed to probe casino operator

QLD to launch Star Entertainment review in July as former judge appointed to probe casino operator

Casino operations that account for more than half of The Star Enter...